Filter
547
Filtered Results: 547
Text search:
Antimalarial
treatment
policy
Featured
Recommendations
52
New Publications
234
Language
Document type
No document type
356
Studies & Reports
77
Guidelines
60
Manuals
17
Strategic & Response Plan
14
Training Material
9
Fact sheets
9
Situation Updates
5
Countries / Regions
Uganda
31
Sierra Leone
25
India
24
Kenya
23
Ghana
22
Global
20
Ethiopia
20
Nigeria
19
Liberia
19
Malawi
17
Tanzania
14
Zambia
13
Rwanda
11
Zimbabwe
11
Senegal
10
Nepal
9
Namibia
9
Latin America and the Carribbean
8
Cameroon
7
Africa
7
Bangladesh
7
Burkina Faso
6
Philippines
6
Mozambique
6
Cambodia
6
South–East Asia Region
6
South Africa
6
Myanmar / Burma
6
East and Southern Africa
4
Indonesia
4
Venezuela
3
Congo, Democratic Republic of
3
West and Central Africa
3
Botswana
3
Eswatini/ Swaziland
3
Thailand
2
China
2
Middle East and North Africa
2
Western and Central Europe
2
Paraguay
2
North America
2
Vietnam
2
Brazil
2
Mali
2
South Sudan
2
Somalia
2
Madagascar
2
Colombia
1
Lesotho
1
Turkey
1
Benin
1
Chile
1
Laos
1
Peru
1
Guinea
1
Haiti
1
Eastern Europe and Central Asia
1
Turkmenistan
1
Southern Africa
1
Bolivia
1
Argentina
1
Lebanon
1
Eastern Europe
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Libya
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
337
Clinical Guidelines
45
Women & Child Health
33
Public Health
21
Key Resources
21
Capacity Building
9
Pharmacy & Technologies
9
Toolboxes
AMR
30
Malaria
29
Pharmacy
24
Ebola & Marburg
12
COVID-19
12
NTDs
11
Rapid Response
10
HIV
8
TB
7
Caregiver
7
Mental Health
5
Health Financing Toolbox
5
Conflict
4
Refugee
3
Planetary Health
3
Natural Hazards
1
Cholera
1
Global Health Education
1
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
The Compendium brings together for the first time key consensus-based policy recommendations and guidance to improve the delivery of proven interventions to women and children. The user-friendly format incorporates icons and tabs to present key health-related policies that support the delivery of es...
South Africa has a long history of community health workers (CHWs). It has been a journey that has required balancing constrained resources and competing priorities. CHWs form a bridge between communities and healthcare service provision within health facilities and act as the cornerstone of South A...
The document outlines essential steps and provides guidance to countries on the adoption and deployment of c-IPTp so that it is integrated into the existing health system. It draws upon best practices and lessons learned from pilot implementation experiences in eight African countries and targets st...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
This interim guidance to national health authorities and blood transfusion services outlines the steps required to collect convalescent whole blood (CWB) or plasma (CP) from Ebola virus disease (EVD) recovered patients for transfusion to patients with early EVD, as an empirical treatment modality.
...
Burkina Faso has approximately 10.5 million inhabitants and is divided into 30 provinces. The study took place in the districts of Tougan, Nouna, and Solenzo, in provinces Sourou and Kossi, in north-west Burkina Faso. There is one medical centre in every district capital and 6 to 14 health centres i...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ...
Statistics and Monitoring Section / Policy and Practice
This policy brief aims to provide a review of the current progress on implementing the Malawi national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing a...
This policy paper underscores that, although children do not represent a high-risk group for direct COVID-19 fatality, the pandemic posts far-reaching secondary impacts that heighten risks to African children’s rights and wellbeing.
